Canopy Growth Corporation (CGC)

37.83
NASDAQ
Prev Close 35.52
Day Low/High 34.34 / 39.10
52 Wk Low/High 9.00 / 36.15
Exchange NASDAQ
Shares Outstanding 373.73B
Market Cap 13.27B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Canopy Might Have Spotted Its Lucky Star in Constellation Brands

Canopy Might Have Spotted Its Lucky Star in Constellation Brands

The cannabis company just brought on STZ executive as new CEO, and this move is likely lining up bigger things to come as sector shakes out.

David Klein Is the Right Guy for the Canopy CEO Job

Canopy Growth embarked on a CEO search in July 2019 after the dismissal of founder and CEO Bruce Linton. The company, at that time, cited the need to bring "new vigor" and organization to Canopy. (Earlier in the year there were investor concerns abo...

Let's Get Chai (Part Deux)

Canopy Growth is higher on news that the former Constellation Brands CFO, David Klein, has become CGC's CEO.

From the Street of Dreams

Bank of America raises Canopy Growth price target to $28 Canadian this morning. On a related note, here is your "Marijuana Moment."

3 Longs

I am picking at the following longs this morning - , and .

Canopy Grows

Canopy Growth is trading well.

Trade of the Week Update

* Let's get "Chai!" A pet peeve I have is that many talking heads don't update their investment ideas on an ongoing basis. I try to be transparent and honest about my winners and losers, and to further improve my own transparency/accountability I am...

My Position Grows in Cannabis

I paid $17.90 for more Canopy Growth here on Tuesday morning. That's my only trade thus far today.

Cannabis a Rising Star in Morningstar Mag

Cannabis a Rising Star in Morningstar Mag

Morningstar Magazine offers insight into future growth potential for cannabis industry and stocks.

More on My Trade of the Week

In my Trade of the Week (Long ) I forgot to include this additional bullet point: * Canopy is heavily shorted. Shorts total 55.5 million shares, up by 3.7 million shares (+7%) over the last month. This compares to average daily trading volume (over ...

Trade of the Week: Buy Canopy Growth

* Let's get "Chai!"  As subscribers know, until recently I have stayed away from a broad-based exposure in the cannabis industry over the last few years, for Canopy Growth , which I thought would be a clear winner because of the imprimatur and the m...

Big News From Weedville

Canopy Growth gets Health Canada license for beverage facility.

Buying More Pot

I bought some more Canopy Growth at $18.25 (down from $21.55/share yesterday afternoon) -- my first buy since I doubled up midweek under $15/share.

Don't Fight the Trend on These 3 Cannabis Stocks

Don't Fight the Trend on These 3 Cannabis Stocks

A look at what the weekly charts of three big cannabis names are saying.

Take 19: My Takeaways

* The 19th nervous breakdown!  * Market breadth was -400 decliners over advancers. (There was a $2.2 billion market on close-sell program.) * The market more than halved its losses from the early afternoon lows. * Bonds rallied and yields dropped by...

5 Memorable Financial Blunders in Cannabis in 2019

5 Memorable Financial Blunders in Cannabis in 2019

These companies didn't make it any easier on themselves this year.

Canopy Growth Is Not Lining Up to Investor Expectations

Canopy Growth Is Not Lining Up to Investor Expectations

CGC reported a wider than expected loss that included a slew of write-downs leading some to conclude this a kitchen sink quarter.

Up in Smoke

My first take on Canopy Growth  (which is down quite a lot today) is that the quarterly loss is above my expectations - reflecting the known inventory glut and disappointing demand in Canada. Also, not unexpectedly, the company wrote down retail inv...

Snacks, Sodas and Sweets: 5 Food & Beverages Stocks That Are Buys

Snacks, Sodas and Sweets: 5 Food & Beverages Stocks That Are Buys

Top picks include blue chips and under-the-radar names.

CGC's Trading Pattern

For the first time in a week, Canopy Growth's   trading pattern is different - it's not lower in the morning (to be followed by strength in the afternoon). Just saying.

Purple Haze (Part Deux)

* Like clockwork! For the sixth day in a row traded lower in the morning and rallied in the afternoon.

Purple Haze?

Maybe I am stoned but for the fifth day in a row has traded lower in the morning only to advance and turn up later in the day.

An Hallucination?

Very odd today. My most speculative cannabis holdings (e.g., iAnthus Capital Holdings  ) are moving up smartly while the less speculative names are languishing. Not sure what, if anything, I should make of this. I would also add that, for the fourth...

Some Good News for Canopy Growth

I have recently passed on observations about the improving patter on performance of shares. Well, on cue, here is some good news from Canopy Growth this morning: European Update: Canopy Growth Secures Exclusive Opportunities in the UK & Luxembourg C...

2 Big-Name Stocks You Should Consider Shorting This Week

2 Big-Name Stocks You Should Consider Shorting This Week

These 'bearish bets' are showing both technical and quantitative deterioration.

Lots of Cannabis

As I have observed, and for the third day in the row, has dipped in the morning and rallied off the lows. I have been a buyer of cannabis all day!

A Trend I Like

"Just one more thing." - Lt Columbo For the third day in a row Canopy Growth pulled back hard in the morning and came back in the afternoon. A trend? I certainly hope so.

With a Little Help From My Friends?

What would you think if I sang out of tune? Would you stand up and walk out on me? Lend me your ears and I'll sing you a song And I'll try not to sing out of key Oh, I get by with a little help from my friends Mm, I get high with a little help from ...

Cut Your Losses on Cannabis Stocks Like Canopy Growth Here

Cut Your Losses on Cannabis Stocks Like Canopy Growth Here

I thought the sector might have been bottoming out, but it's not.

Jefferies' Cannabis Downgrades Could Provide Bottom Sector Needs

Jefferies' Cannabis Downgrades Could Provide Bottom Sector Needs

This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.